Genotoxicity

Genotoxicity refers to the property of chemical agents or physical factors that damage the genetic information within a cell, causing mutations or chromosomal aberrations. It is not a specific protein, enzyme, or receptor, but rather a critical toxicological endpoint and safety property evaluated during drug discovery and development. Genotoxic damage can occur through direct interaction with DNA, such as alkylation or intercalation, or indirectly by interfering with the machinery of DNA replication and repair. While genotoxicity is a major safety concern for most therapeutic classes because it can lead to cancer and hereditary defects, it is often a desired mechanism of action for certain cytotoxic chemotherapies designed to kill rapidly dividing tumor cells. Regulatory guidelines, such as those from the International Council for Harmonisation (ICH), mandate a battery of genotoxicity tests, including the Ames test and micronucleus assay, to identify potential mutagenic risks before human clinical trials. Understanding the genotoxic potential of a compound is essential for establishing risk-benefit ratios and ensuring long-term patient safety against secondary malignancies.

Other names

DNA damageMutagenicityClastogenicityAneugenicityGenotoxic stress

In the context of cytotoxic drugs, genotoxicity is achieved through DNA alkylation, DNA strand cross-linking, intercalation between base pairs, or the inhibition of topoisomerase enzymes, all of which induce double-strand breaks and trigger apoptosis in target cells.